Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71551 - 71575 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	MAL2	114569	downregulated	Silicon Dioxide analog results in decreased expression of MAL2 mRNA	8q24.12	A24195
Silicon dioxide	Approved	MAMLD1	10046	upregulated	Silicon Dioxide results in increased expression of MAMLD1 mRNA	Xq28	A24196
Silicon dioxide	Approved	MAN1A2	10905	downregulated	Silicon Dioxide results in decreased expression of MAN1A2 mRNA	1p12	A24196
Silicon dioxide	Approved	MAN1C1	57134	downregulated	Silicon Dioxide analog results in decreased expression of MAN1C1 mRNA	1p36.11	A24195
Silicon dioxide	Approved	MANSC1	54682	downregulated	Silicon Dioxide analog results in decreased expression of MANSC1 mRNA	12p13.2	A24195
Silicon dioxide	Approved	MAOB	4129	downregulated	Silicon Dioxide analog results in decreased expression of MAOB mRNA	Xp11.3	A24195
Silicon dioxide	Approved	MAP1B	4131	upregulated	Silicon Dioxide analog results in increased expression of MAP1B mRNA	5q13.2	A24195
Silicon dioxide	Approved	MAP1LC3B	81631	upregulated	Silicon Dioxide analog results in increased expression of MAP1LC3B mRNA	16q24.2	A24195
Silicon dioxide	Approved	MAP2K3	5606	upregulated	Silicon Dioxide analog results in increased expression of MAP2K3 mRNA	17p11.2	A24195
Silicon dioxide	Approved	MAP2K3	5606	upregulated	Silicon Dioxide results in increased expression of MAP2K3 mRNA	17p11.2	A24196
Silicon dioxide	Approved	MAP2K5	5607	downregulated	Silicon Dioxide results in decreased expression of MAP2K5 mRNA	15q23	A24196
Silicon dioxide	Approved	MAP2K6	5608	downregulated	Silicon Dioxide analog results in decreased expression of MAP2K6 mRNA	17q24.3	A24195
Silicon dioxide	Approved	MAP2K6	5608	downregulated	Silicon Dioxide results in decreased expression of MAP2K6 mRNA	17q24.3	A24197
Silicon dioxide	Approved	MAP3K10	4294	upregulated	Silicon Dioxide analog results in increased expression of MAP3K10 mRNA	19q13.2	A24195
Silicon dioxide	Approved	MAP3K14	9020	upregulated	Silicon Dioxide analog results in increased expression of MAP3K14 mRNA	17q21.31	A24195
Silicon dioxide	Approved	MAP3K2	10746	upregulated	Silicon Dioxide analog results in increased expression of MAP3K2 mRNA	2q14.3	A24194
Silicon dioxide	Approved	MAP3K20	51776	downregulated	Silicon Dioxide analog results in decreased expression of MAP3K20 mRNA	2q31.1	A24195
Silicon dioxide	Approved	MAP3K7CL	56911	downregulated	Silicon Dioxide analog results in decreased expression of MAP3K7CL mRNA	21q21.3	A24195
Silicon dioxide	Approved	MAP6	4135	downregulated	Silicon Dioxide analog results in decreased expression of MAP6 mRNA	11q13.5	A24195
Silicon dioxide	Approved	MAP6D1	79929	upregulated	Silicon Dioxide analog results in increased expression of MAP6D1 mRNA	3q27.1	A24195
Silicon dioxide	Approved	MAP7D3	79649	upregulated	Silicon Dioxide analog results in increased expression of MAP7D3 mRNA	Xq26.3	A24195
Silicon dioxide	Approved	MAP9	79884	upregulated	Silicon Dioxide analog results in increased expression of MAP9 mRNA	4q32.1	A24194
Silicon dioxide	Approved	MAPK10	5602	downregulated	Silicon Dioxide analog results in decreased expression of MAPK10 mRNA	4q21.3	A24195
Silicon dioxide	Approved	MAPK10	5602	downregulated	Silicon Dioxide results in decreased expression of MAPK10 mRNA	4q21.3	A24196
Silicon dioxide	Approved	MAPK13	5603	upregulated	Silicon Dioxide analog results in increased expression of MAPK13 mRNA	6p21.31	A24195

Displaying entries 71551 - 71575 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability